The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region

Journal of Endocrinological Investigation

Volumn 27, Issue 9, 2004, Pages 807-812

  Raef, H ^a   Ingemansson, S ^a   Sobhi, S ^a   Sultan, A ^a   Ahmed, M ^a   Chaudhry, M ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Hyperparathyroidism; Metabolic bone disease; Vitamin D

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; VITAMIN D;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANALYSIS OF VARIANCE; ARTICLE; BONE RADIOGRAPHY; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; FATIGUE; FEMALE; FISHER EXACT TEST; HISTOPATHOLOGY; HUMAN; HYPOCALCEMIA; MALE; METABOLIC BONE DISEASE; MUSCULOSKELETAL DISEASE; PARATHYROID ADENOMA; PARATHYROID FUNCTION; PARATHYROIDECTOMY; POSTOPERATIVE COMPLICATION; PRIMARY HYPERPARATHYROIDISM; RETROSPECTIVE STUDY; RISK FACTOR; SYMPTOMATOLOGY; TUMOR VOLUME; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 14544285614     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346273     Document Type: Article

References (25)

1. Silverberg SJ, Fitzpatrick LA, Bilezikian JP. Primary hyperthyroidism. In: Becker KL ed. Principles and Practice of Endocrinology and Metabolism. 2nd ed. Philadelphia: J.B. Lippincott Company. 1995, 512-20.
2. Harinarayan CV, Gupta N, Kochupillai N. Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol (Oxf) 1995, 43: 351-8.
3. Woodhouse NJY, Norton WL. Low vitamin D levels in Saudi Arabians. King Faisal Specialist Hospital Medical Journal 1982, 2: 127-31.
4. Fouda MA. Primary hyperparathyroidism: King Khalid University Hospital Experience. Ann Saudi Med 1999, 19: 110-5.
5. Ingemansson SG, Hugosson CH, Woodhouse NJY. Vitamin D deficiency and hyperparathyroidism with severe bone disease. World J Surg 1988, 12: 517-21.
6. Rao DS, Honasoge M, Divine GW, et al. Effectof vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab 2000, 85: 1054-8.
7. Wortsman J, Haddad JG, Posillico JT, Brown EM. Primary hyperparathyroidism with low serum 1,25-dihydroxyvitamin D levels. J Clin Endocrinol Metab 1986, 62: 1305-8.
8. Khosla S, Ebeling PR, Fireck AF, Burritt MM, Kao PC, Heath H 3rd. Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. J Clin Endocrinol Metab 1993, 76: 715-20.
9. Malberti F, Farina M, Imbasciati E. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism. Nephrol Dial Transplant 1999, 14: 2398-406.
10. Fuleihan GEH. Pathogenesis and etiology of primary hyperparathyroidism. UpToDate, Inc. 1997.
11. Silver J, Yalcindag C, Sela-Brown A, Kilav R, Naveh-Many T. Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate. Kidney Int 1999, 56 (Suppl. 73): 2-7.
12. Cetani F, Pinchera A, Pardi E, et al. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. J Bone Miner Res 1999, 14: 878-82.
13. Carling T, Ridefelt P, Hellman P, Rastad J, Akerstrom G. Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism. J Clin Endocrinol Metab 1997, 82: 1772-5.
14. Correa P, Rastad J, Schwarz P, et al. The vitamin D receptor (VDR) start codon polymorphism in primary hyperparathyroidism and parathyroid VDR messenger ribonucleic acid levels. J Clin Endocrinol Metab 1999 84: 1690-4.
15. Sudhaker Rao DS, Han Z-H, Phillips ER, Palnitkar S, Parfitt AM. Reduced Vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis. Clin Endocrinol (Oxf) 2000, 53: 373-81.
16. Carling T, Rastad J, Szabo E, Westin G, Akerstrom G. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. J Clin Endocrinol Metab 2000, 85: 2000-3.
17. Lumb GA, Stanbury SW. Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism. Am J Med 1974, 56: 833-9.
18. Kleeman CR, Norris K, Coburn JW. Is the clinical expression of primary hyperparathyroidism a function of the long-term vitamin D status of the patient? Mineral Electrolyte Metab 1987, 13: 305-10.
19. Vaishnava H, Rizvi SNA. Primary hyperparathyroidism associated with nutritional osteomalacia. Am J Med 1969, 46: 640-4.
20. Sultan AH, Bruckner FE, Eastwood JB. Association between prolonged dietary vitamin D deficiency and autonomous hyperparathyroidism. BMJ 1989, 299: 236-7.
21. Silverberg SJ, Shane E, Dempster DW, Bilezikian JP. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 1999, 107: 561-7.
22. Paillard M, Gardin J-P, Borensztein P, Prigent A. Determinants of parathormone secretion in primary hyperparathyroidism. Horm Res 1989, 32: 89-92.
23. Coen G, Bondatti F, de Matteis A, et al. Severe vitamin D deficiency in a case of primary hyperparathyroidism caused by parathyroid lipoadenoma, effect of 25OHD3 treatment. Miner Electrolyte Metab 1989, 15: 332-7.
24. Bilezikian JP, Meng X, Shi Y, Silverberg SJ. Primary hyperparathyroidism in women: a tale of two cities: New York and Beijing. Int J Fertil Womens Med 2000, 45: 158-65.
25. Miedlich S, Krohn K, and Paschke R. Update on genetic and clinical aspects of primary hyperparathyroidism. Clinical Endocrinol (Oxf) 2003, 59: 539-54.